University of Kentucky

UKnowledge
Behavioral Science Faculty Publications

Behavioral Science

1-2019

Lung Cancer Screening in a Community Setting: Characteristics,
Motivations, and Attitudes of Individuals Being Screened
Margaret M. Byrne
Moffitt Cancer Center

Sarah E. Lillie
Minneapolis Veterans Affairs Health Care System

Jamie L. Studts
University of Kentucky, jamie.studts@uky.edu

Follow this and additional works at: https://uknowledge.uky.edu/behavsci_facpub
Part of the Behavior and Behavior Mechanisms Commons, Community Health and Preventive
Medicine Commons, and the Oncology Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Byrne, Margaret M.; Lillie, Sarah E.; and Studts, Jamie L., "Lung Cancer Screening in a Community Setting:
Characteristics, Motivations, and Attitudes of Individuals Being Screened" (2019). Behavioral Science
Faculty Publications. 52.
https://uknowledge.uky.edu/behavsci_facpub/52

This Article is brought to you for free and open access by the Behavioral Science at UKnowledge. It has been
accepted for inclusion in Behavioral Science Faculty Publications by an authorized administrator of UKnowledge.
For more information, please contact UKnowledge@lsv.uky.edu.

Lung Cancer Screening in a Community Setting: Characteristics, Motivations, and
Attitudes of Individuals Being Screened
Digital Object Identifier (DOI)
https://doi.org/10.1177/2055102918819163

Notes/Citation Information
Published in Health Psychology Open, v. 6, issue 1, p. 1-9.
© The Author(s) 2019
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0
License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use,
reproduction and distribution of the work without further permission provided the original work is
attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/openaccess-at-sage).

This article is available at UKnowledge: https://uknowledge.uky.edu/behavsci_facpub/52

819163
research-article20182018

HPO0010.1177/2055102918819163Health Psychology OpenByrne et al.

Report of empirical study

Lung cancer screening in a community
setting: Characteristics, motivations, and
attitudes of individuals being screened

Health Psychology Open
January-June 2019: 1–9
© The Author(s) 2019
Article reuse guidelines:
sagepub.com/journals-permissions
https://doi.org/10.1177/2055102918819163
DOI: 10.1177/2055102918819163
journals.sagepub.com/home/hpo

Margaret M Byrne1, Sarah E Lillie2 and Jamie L Studts3

Abstract
We describe the characteristics of individuals being screened in community settings including factors influencing screening
decisions and the level of information sought prior to screening. Individuals from two community-based radiology clinics
(N = 27) were surveyed after screening. Screening efficacy and salience were the most important factors in screening
decisions, whereas healthcare provider recommendations were rated not important. Half of participants reported no or
little conversation about screening with their primary care provider, and 61.5 percent had not sought any information on
screening. Individuals being screened in a community setting are unlikely to have sufficient information for an informed
decision about screening.
Keywords
decision-making, early adoption, information, low-dose computed tomography, lung cancer screening

Introduction
Lung cancer has long been the leading cause of cancer deaths
among adults in the United States, with 234,030 new cases
and 154,050 estimated for 2018 (American Cancer Society
(ACS), 2018). After the National Lung Screening Trial
(NLST) findings in 2011 showed a substantial relative reduction in lung cancer mortality with low-dose computed
tomography (LDCT) screening (Aberle et al. 2011), the US
Preventive Services Task Force (USPSTF) recommended
lung cancer screening for specific high-risk populations
(Moyer and USPSTF, 2014), and in 2015, Medicare and private insurance began to provide coverage of LDCT screening for lung cancer. Following these policy changes,
advocates, researchers, and health care providers anticipated
a strong upsurge in screening rates and hoped that lung cancer screening might provide a teachable moment regarding
smoking cessation (Lennes et al., 2018). However, anecdotal
evidence and two recent studies (Huo et al., 2017; Jemal and
Fedewa, 2017) have shown lower than expected rates of
screening among individuals for whom screening is recommended based on their smoking history.
It is important to recognize that recommendations for
lung cancer screening are more targeted to specific

populations than other cancer screening recommendations,
as screening has only been shown to be efficacious in
reducing mortality in a specific set of individuals. Therefore,
a general or population-wide increase in screening rates,
such as has been seen with breast cancer screening interventions (Anastasi and Lusher, 2017), is not necessarily
desirable. Rather, lung cancer screening programs should
aim to raise awareness, provide education, and promote
engagement in shared decision-making, so that individuals
have the knowledge and support to determine whether
screening is right for them. Therefore, provision of information and guidelines for shared decision-making regarding lung cancer screening must be cognizant of the attitudes,
motivations, and information needs of individuals who are
making decisions about lung cancer screening.
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Along these lines, a number of recent studies have
explored individuals’ attitudes toward and interest in lung
cancer screening. For example, Lillie et al. (2018) found
that need for cognitive closure was not associated with lung
cancer screening uptake in veterans. However, for the most
part, these studies have focused on individuals participating
in a lung cancer screening trial (e.g. Patel et al., 2012; Van
den Bergh et al., 2009) or are survey studies of individuals
who are not and/or have not been screened for lung cancer,
but rather have been recruited from the general public or
through a primary care setting (e.g. Delmerico et al., 2014;
Jonnalagadda et al., 2012; Pallin et al., 2012; Silvestri et al.,
2007; Tanner et al., 2013). Therefore, there is a lack of
information in the literature about factors affecting screening decisions, attitudes toward screening, and information
sought about screening in individuals who are actually
undergoing screening lung cancer screening outside of a
research setting. Although these data were collected before
the NLST results, we nevertheless believe that the choice
setting represented in our study is more relevant and comparable to current community-based settings for decisionmaking about lung cancer screening than other studies
undertaken in the context of a trial or hypothetical (survey)
choice situation.
The study reported here addresses this gap in knowledge
by presenting information collected from individuals
receiving lung cancer screening in a community setting.
Although these data pre-date the NLST trial results and
subsequent policy changes, the decisions made regarding
screening reported here closely mirror actual communitybased decisions about screening than the more frequently
studied situations of screening in a screening trial setting or
hypothetical screening questions.

Materials and methods
Participants and procedures
Eligible participants for this study were adults who had previously received at least one LDCT between February 2008
and June 2009 at one of two community-based direct outpatient radiology clinics in Florida and Kentucky. The
study sample was recruited through two means: (1) the
clinics distributed study flyers as potentially eligible
patients arrived for their LDCT and (2) the clinics mailed
an invitation letter to the 92 patients who had received an
LDCT any time within the past year (Florida study site: 50
patients; Kentucky study site: 42 patients). Interested participants self-referred into the study. Participation was open
regardless of gender, age, and race/ethnicity; however, individuals were excluded if they were incapable of completing
a survey in English. Eligibility was confirmed and informed
consent subsequently obtained either at the study site
(Kentucky study site) or via telephone or mail (Florida
study site). The survey was completed either during a
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scheduled study visit (Kentucky study site) or via mail
(Florida study site). Participants received a US$60 gift card
after completing the survey. The protocol was approved by
the Institutional Review Boards of the University of Miami
and the University of Kentucky.

Measures
Sample characteristics. Participants reported basic demographics (e.g. age, gender, race/ethnicity, highest educational attainment, marital status, employment status, annual
household income), as well as general health, type of insurance, smoking history, and number of previous LDCT
scans (including results) on the survey. In addition, individuals were asked whether they believed that they were at
risk for developing lung cancer (yes/no).
Factors important in the decision to be screened for lung cancer. To identify possible influences on the decision to be
screened in the community setting, participants rated 22
decision-making factors which potentially affected their
past decision to be screened for lung cancer and 8 decisionmaking factors which might affect future LDCT decisionmaking. The factors were rated on a 10-point Likert-type
scale (1 = not at all important to 10 = very important) and
addressed barriers to screening, screening clinic and physician characteristics, screening efficacy, fear, social influence, lung cancer screening attributes, and salience (see
Table 2 for the complete list of factors and results). The
specific factors were selected as likely relevant to lung cancer screening decision-making from a systematic literature
review as well as health behavior theory (Ajzen, 1991;
Becker, 1974; Carter-Harris et al., 2016). For analyses, factors were categorized into three groups based on the overall
mean scores: not important = 1–4.9, somewhat important = 5–7.9, and very important = 8–10. A mean summary
importance score was also calculated.
Sources of lung cancer screening information. Main sources of
lung cancer screening information were assessed in two
ways. First, participants were asked to what degree they
had discussed lung cancer screening with any of the following people: family, friends, primary care physician, other
physicians, nurses, others (response options: never, a little
bit, some, a fair bit, extensively). Second, respondents indicated whether they had sought information on lung cancer
screening from any of the following sources: screening
center website, other Internet sites, a cancer hotline such as
the Cancer Information Service operated by the National
Cancer Institute, a community health center, or another
source (write-in answer).
Evaluation of lung cancer screening decision. Participants
assessed their overall lung cancer screening experience
using a 5-point Likert-type scale (1 = very negative to
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5 = very positive) and asked whether they would be interested in future lung cancer screening using a 5-point Likerttype scale (1 = definitely no to 5 = definitely yes).
Participants also completed three validated scales to evaluate their screening decision: (1) the 5-item Decision Regret
Scale (Brehaut et al., 2003), which measures distress or
remorse after a healthcare decision (1 = strongly agree to
5 = strongly disagree; higher mean scores indicate lower
decision regret), with a sixth lung cancer–specific item (“I
am aware of the choices I have to participate in lung cancer
screening”); (2) the 6-item Satisfaction with Decision Scale
(Holmes-Rovner et al., 1996), which measures participants’
satisfaction with a health care decision (1 = lowest satisfaction to 5 = highest satisfaction; higher mean scores indicate
higher decision satisfaction); and (3) the 16-item Decisional Conflict Scale (O’Connor, 1995), which measures
personal perceptions of decision uncertainty (0 = strongly
agree to 4 = strongly disagree; higher mean scores indicate
greater decisional conflict) using five sub-scales that focus
on uncertainty, informed, values clarity, support, and effective decisions.

Statistical analyses
We report means and standard deviations for continuous
variables and frequencies and percentages for all other data.
Group differences in factors important to screening decisions were compared by smoking status, gender, and age.
Comparisons of mean differences in decision regret, decision satisfaction, and decisional conflict by smoking status,
gender, and age were performed using t tests. Because a
significant difference in age was found between the
Kentucky and Florida subsets of the sample, we explored
conducting analyses stratified by location. However,
because of concerns of small sample size and multiple
comparisons leading to potentially spurious significant
results, we do not include those analyses here. All analyses
were performed using STATA v. 13 (StataCorp LP, College
Station, TX, USA).

Results
Sample characteristics
There were 27 individuals undergoing LDCT-based lung
cancer screening in our two community clinics who participated in our survey. The Florida study site recruited 13 participants through the study invitation letter (26% response
rate), and the Kentucky study site recruited 14 participants
through the study invitation letter (n = 13; 31% response
rate) and the clinic-distributed flyers (n = 1). Participants
had an average age of 59.5 years (standard deviation (SD)
9.1). They were primarily female (61.5%), White (92.3%),
and living with a spouse (80.8%). Reflecting the lack of
insurance or Medicare coverage of screening at the time,

our study population was financially stable: 48.2 percent
were in the highest income bracket (over US$75,000/year),
63.0 percent had private insurance, and 57.7 percent had at
least a college degree. The majority of respondents reported
themselves as healthy (92.6%) and 63.0 percent were not
current smokers. Just over half (n = 15; 55.6%) of participants had received only one previous LDCT scan, and
74.1 percent believed that they were at risk of developing
lung cancer. There were no statistically significant differences between participants drawn from the Kentucky and
Miami study sites on gender, race/ethnicity, highest educational attainment, annual household income, general health
status, or smoking status (current vs former smoker).
However, participants from the Kentucky study site were
younger than those from the Florida study site (mean age
56.0 vs 63.7, p = 0.03). Full participant characteristics are
presented in Table 1.
We compared the demographic characteristics of our
study sample to that of the communities from which they
originate (from US Census Bureau 2016 American
Community Survey 5-year estimates, Boca Raton, FL (FL)
and Lexington, KY (KY), respectively). The study sample
is somewhat older (median age 46.3 FL and 34.1 KY), had
a higher percentage of women (51.5% FL and 50.9% KY, in
Lexington), but had similar racial demographics (88.6%
White in FL and 75.8% White in KY).

Factors important in the decision to be screened
for lung cancer
Participants’ ratings of the importance of factors affecting
past and future lung cancer screening decisions are shown
in Table 2. Overall, the most important factor in the decision to be screened was the ability to detect lung cancer
early (mean: 9.93, SD 0.38). The majority of factors designated as very important related to lung cancer screening
attributes and efficacy: being forewarned of any potential
future health problems (mean: 9.37, SD 1.57), reassurance
that one’s lungs were healthy (mean: 9.31, SD 2.02), reducing the risk of dying from lung cancer (mean: 9.22, SD
2.15), and screening having no major side effects (mean:
8.30, SD 2.84). Other factors rated very important were
considering health to be very important (mean: 9.58, SD
1.03) and the fear of being diagnosed with lung cancer
(mean: 8.16, SD 3.12).
The majority of factors relating to social influence were
identified as not important in the lung cancer screening
decision, including a doctor’s recommendation (mean:
4.42, SD 4.27). Although the participants identified the cost
of lung cancer screening as a somewhat important factor
(mean: 6.48, SD 3.30), they identified the two factors
related to cost-cutting as not important: having a coupon to
reduce the cost of screening (mean: 4.25, SD 3.97) and
receiving a discount on screening (mean: 4.71, SD 3.84).
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Table 1. Sample characteristics (n = 27).
Variable

Table 1. (Continued)
n (%)a

Age, mean (SD) (years)
59.5 (9.06)
Gender
Male
10 (38.5)
Female
16 (61.5)
Race/ethnicity
White, non-Hispanic
24 (92.3)
Black
2 (7.7)
Other
0 (0)
Highest level of education
High school graduate or less
3 (11.5)
Some technical or college training
8 (30.7)
College graduate
6 (23.1)
Postgraduate work
9 (34.6)
Marital statusb
Live with spouse
21 (80.8)
Live with children
2 (7.7)
Live alone
4 (15.4)
Other
3 (11.5)
Work outside of the home
Yes, full-time
13 (48.2)
Yes, part-time
4 (14.8)
No
10 (37.0)
Household income
Less than US$20,000
2 (7.4)
US$20,000–35,000
2 (11.1)
US$35,000–50,000
4 (14.8)
US$50,000–75,000
2 (7.4)
Over US$75,000
13 (48.2)
Refused
3 (11.1)
General health
Excellent
6 (22.2)
Very good
8 (29.6)
Good
11 (40.7)
Fair
2 (7.4)
Poor
0 (0)
Insuranceb
Private
17 (63.0)
Medicare
7 (25.9)
Medicaid
1 (3.7)
VA
3 (11.1)
No insurance
5 (18.5)
Smoking history
Never smoker
5 (18.5)
Former smoker
12 (44.4)
Current smoker
10 (37.1)
Pack year exposure, mean (SD)
22.3 (16.6)
Previous LDCT
1
15 (57.7)
2 or more
10 (38.5)
Do you believe that you are at risk for lung cancer?
Yes
20 (74.1%)
No
7 (25.9%)

Variable

n (%)a

Compared to others your same age, how would you describe
your risk for lung cancer?
A lot lower than average
2 (7.4)
Lower than average
3 (11.1)
About average
6 (22.2)
Higher than average
9 (33.3)
A lot higher than average
7 (25.9)
SD: standard deviation; LDCT: low-dose computed tomography.
aPercentages may not sum to 100 percent due to non-response.
bRespondents checked all that applied.

With regard to factors potentially affecting future screening, participants identified most barriers or clinic attributes
as very important (not waiting long to get an appointment,
ease of scheduling, and being seen on time) or somewhat
important (that the results were explained by a physician at
the center, the pleasantness of the staff at the center, how
inviting the clinic was, and how close the clinic was to
home). Only one factor, how close the clinic was to work,
was identified as not important in future lung cancer screening decision-making (mean: 3.88, SD 3.26).

Variations in factors important to lung cancer
screening uptake
As shown in Table 2, there were statistically significant
variations in importance ratings by smoking status, gender,
and age. In some of these instances, the differences are substantial enough so that stratifying the population responses
leads to a different categorization of importance of a factor
for the different population strata. These instances are highlighted below in labeling each factor as NI = not important,
SI = somewhat important, and VI = very important for those
cases where the stratified analyses result in different categorizations for different subpopulations.
Not surprisingly, smokers reported smoking history (SI
overall) being of more importance to lung cancer screening
decision-making than did non-smokers (9.40 (VI) vs 6.50
(SI)). Using a summary measure, women globally rated all
decision-making factors more importantly than did men:
7.10 vs 5.58. Specifically, attributes of the lung cancer
screening test and results seemed to be more important to
women than to men (i.e. low false-positive rate (SI overall):
6.87 (SI) vs 4.33 (NI); painless screening exam (SI overall): 8.63 (VI) vs 6.30 (SI); ability of screening to reduce
the risk of dying from lung cancer: 9.75 vs 8.30), as were
clinic/physician attribute associations with future screening
decisions (how inviting the clinic was: 7.31 vs 5.10; pleasantness of the staff at the center (SI overall): 8.25 (VI) vs
5.20 (SI); being seen on time for the appointment (VI
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Table 2. Factors important to lung cancer screening decisions (n = 27).
Mean (SD)a

Significant associations
Smoking status
Current vs former/
never

Gender
Female vs male

Age
⩽60 vs >60

2.40 (2.90)
2.46 (2.96)
3.12 (3.54)
3.88 (3.75)
4.08 (3.98)
4.13 (3.87)
4.25 (3.97)
4.42 (4.27)
4.71 (3.84)

NS
NS
NS
NS
NS
NS
NS
NS
NS

2.73 vs 1.00*
3.00 vs 1.00*
4.07 vs 1.00**
NS
NS
NS
5.21 vs 2.11*
NS
5.93 vs 2.22**

NS
NS
NS
NS
NS
NS
NS
NS
NS

6.04 (3.85)

NS

NS

NS

6.08 (3.58)
6.48 (3.30)
7.62 (3.81)
7.78 (3.32)
7.81 (3.06)

NS
NS
9.40 vs 6.50*
NS
NS

6.87 vs 4.33*
NS
NS
NS
8.63 vs 6.30*

NS
NS
NS
NS
NS

8.16 (3.12)
8.30 (2.84)
9.22 (2.15)

NS
NS
NS

NS
NS
9.75 vs 8.30*

NS
NS
NS

9.31 (2.02)
9.37 (1.57)
9.58 (1.03)
9.93 (0.38)

NS
NS
NS
NS

NS
NS
NS
NS

NS
NS
9.08 vs 10**
NS

3.88 (3.26)

NS

NS

NS

6.04 (3.07)
6.59 (3.07)
7.19 (2.77)
7.23 (3.65)

NS
NS
NS
NS

NS
7.31 vs 5.10*
8.25 vs 5.20**
NS

NS
NS
NS
5.75 vs 8.50*

8.22 (2.45)
8.33 (2.35)
8.48 (2.34)

NS
NS
NS

9.06 vs 6.70**
NS
NS

NS
NS
NS

Previous lung cancer screening decision
Factors rated not important
A friend thought they should be screened (I)
A friend recommended the screening (I)
A friend had the same type of screening before (I)
A family member had the same type of screening (I)
A family member recommended the screening (I)
A family member thought they should be screened (I)
They had a coupon to reduce the cost of screening (B)
A doctor recommended the screening (I)
They received a discount on the screening (B)
Factors rated somewhat important
They saw or heard an advertisement for the screening on the
TV, newspaper, or radio (I)
The low false-positive rate (L)
The cost of the screening exam (B)
Their smoking history (S)
Whether the lung screening physician is board certified (C)
That the screening exam was painless (L)
Factors rated very important
Fear of being diagnosed with lung cancer (F)
That screening had no major side effects (L)
The ability of screening to reduce the risk of dying from lung
cancer (E)
They wanted to be reassured that their lungs were healthy (L)
Being forewarned of any potential future health problems (L)
Because their health is very important to them (S)
The ability of screening to detect lung cancer early (E)
Future lung cancer screening decision
Factors rated not important
How close the clinic was to work (B)
Factors rated somewhat important
How close the clinic was to home (B)
How inviting the clinic was (C)
The pleasantness of the staff at the center (C)
The results were explained by a physician at the center (C)
Factors rated very important
That they would be seen on time for appointment (C)
That it was easy to schedule the appointment (B)
That they did not have to wait very long to get an
appointment (C)

B: barriers; C: clinic/physician attributes; E: efficacy of screening; F: fear; I: social influence; L: lung cancer screening attributes; S: salience; NS: not
significant.
aScale of 1–10 with 1 being “not at all important” and 10 being “very important.”
*p < 0.05; **p < 0.01.

overall): 9.06 (VI) vs 6.70 (SI)). In addition, women rated
the social influence of friends and some financial factors,
indicating cost-related barriers, as more important than

men. However, despite between-group differences, both
men and women identified these factors as generally unimportant. Finally, older adults rated a screening center
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Figure 1. Lung cancer screening discussions (n = 27).

physician explaining the LDCT results (SI overall) (8.50
(VI) vs 5.75 (SI)) and the importance of their own health
(10.00 vs 9.08) as more important than younger adults.

Sources of lung cancer screening information
Figure 1 shows the extent of screening discussions that participants engaged in with specific types of people. Overall,
most participants did not extensively discuss lung cancer
screening with any category of potential discussants before
being screened. In describing the extent of discussions
about lung cancer screening, 37.5 percent of participants
revealed that they had never spoken with a primary care
physician before being screened. Similarly, 36.0 percent
had never spoken with family members and 52.2 percent
never with friends about lung cancer screening before
screening. Overall, 18.5 percent of participants selected
“never” for all categories in Figure 1, indicating that they
had not spoken with anyone before being screened.
In addition, participants were asked whether they had
sought information from a variety of sources such as the
Internet, a telephone call in line such as the Cancer
Information Service, or other. The majority (61.5%) indicated that they had not sought information from any sources.
Of the 11 individuals, 10 who reported seeking information
used Internet-based resources, predominantly the webpage
of the specific radiology clinic where they were screened.

Evaluation of lung cancer screening decision
The majority of participants indicated that they had a positive or very positive lung cancer screening experience

(85.2%) and would “probably” or “definitely” be screened
again (88.9%). No participant reported having a very negative screening experience.
Figure 2 shows how participants evaluated their lung cancer screening decision as measured by several validated survey instruments related to decision-making. Results are
given for the overall population and for the population stratified by smoking status, gender, and age category. Participants
indicated low decisional regret (mean: 26.58, SD 4.62) and
high satisfaction with the decision (mean: 26.04, SD 6.46).
For decisional regret, where higher scores indicate less
regret, women had significantly lower decisional regret than
did men (mean: 28.2 vs 25.6). Younger individuals had
higher decision satisfaction than did older individuals (mean:
28.1 vs 23.6). Participants reported low conflict levels based
on the Decisional Conflict Scale (mean score: 21.2, SD
18.6), with women and current smokers having lower decisional conflict than men and former smokers (mean: 25.20 vs
32.3, 26.1 vs 31.8, respectively).

Discussion
In an effort to understand the factors that were important to
individuals who were early adopters of lung cancer screening, we collected novel information from an important and
unique sample of individuals who had been screened for
lung cancer with LDCT in community settings. Although
these individuals were screened prior to the NLST results
and coverage of screening, their responses are more relevant than most previous studies reporting this information,
as these people had made real—as opposed to hypothetical—decisions about screening and were screened in the
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Figure 2. Evaluation of lung cancer screening decision (n = 27).

community as opposed to being screened within an ongoing screening trial. Overall, these results suggest that participants positively appraised their lung cancer screening,
and they elected to pursue screening with an expectation
that it would effectively detect lung cancer early, implicitly
reduce the risk of lung cancer death, and/or definitively
ascertain lung health.
Several findings from this study are especially noteworthy and warrant consideration alongside efforts to implement
high-quality lung cancer screening among individuals at
high risk of lung cancer across the nation and globally. First,
our results identify a largely homogeneous population who
received LDCT-based lung cancer screening. Despite being
from different locations, the demographics of our sample
indicate a White, female, and financially stable group of
screeners who, despite their high level of education, did not
seek much information prior to screening. In addition,
despite their elevated perceived lung cancer risk, these individuals were not uniformly at high risk for lung cancer. In
fact, the majority (70%) of our participants would not meet
the USPSTF recommended criteria for screening.
Second, we found that there were interesting variations
by participant characteristics in both the identification of
important lung cancer screening decision-making factors
and the evaluation of lung cancer screening. In some
cases, stratified analyses resulted in disparate classifications of the importance of a factor for different subpopulations. (Note, however, that the classification definitions
were subjective and not statistically determined.) Female
participants globally rated decision-making factors more
important than their counterparts and specifically rated
screening efficacy factors, clinic attribute factors, and
cost-related barrier factors more important than did men.
Although social influence factors were rated as relatively

unimportant to decision-making overall, women valued
these factors significantly more than men. In contrast to
finding that social influence was not important in lung
cancer screening decisions in this population, Braybrook
et al. (2011) reported that family members improved
men’s awareness of lung cancer screening, especially if a
family member already had cancer. Therefore, it is unclear
what role family members may play in uptake of lung cancer screening in response to newly crafted screening
guidelines. In families with a family history of lung cancer, this might engender support for screening; however,
family communication patterns regarding smoking and
tobacco cessation efforts might actually complicate efforts
to raise awareness or encourage consideration of lung
cancer screening.
Women also experienced lower decision regret and
lower decisional conflict regarding lung cancer screening
participation decisions. Older individuals placed more
importance on screening center physicians explaining the
lung cancer screening results and the importance of their
own health and experienced lower decision satisfaction
than younger participants. Not surprisingly, current smokers placed more importance on their smoking history; former and never smokers placed importance on their health in
general and experienced higher decisional conflict in the
informed and values clarity domains, indicating that nonsmokers receiving lung cancer screening were least prepared to make informed choices. This follows previous
research findings that current, former, and never smokers
have disparate attitudes toward lung cancer screening
(Jonnalagadda et al., 2012).
Finally, and perhaps most striking, our results suggest
that informed decision-making for lung cancer screening
was not occurring among all participants. A healthcare
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provider recommendation for lung cancer screening was
not highly valued, nor was healthcare provider consultation
commonly sought. While physicians currently lack detailed
knowledge regarding lung cancer screening efficacy, evidence, and guidelines (Klabunde et al., 2012), alternative
information sources, such as direct to consumer advertising, commonly focus solely on benefits and do not impart
adequate knowledge of screening harms (Illes et al., 2004).
Indeed, early adopters emphasized the benefits of lung cancer screening, as they classified these factors as very important but did not call attention to potential harms. This
finding follows a general trend of people overestimating
benefits of screening and underestimating harms (Schwartz
et al., 2004) and is of notable concern in the context of
LDCT-based lung cancer screening; there are a number of
significant high-probability and low-probability harms
associated with screening and follow-up procedures,
including overdiagnosis (Patz et al., 2014), high rates of
false positives and indeterminate pulmonary nodules, and
significant incidental findings (Aberle et al., 2011; Petersen,
2014) that may lead to psychosocial distress (Byrne et al.,
2008; Slatore et al., 2014; Van den Bergh et al., 2010;
Wiener et al., 2015), increased health care resources (Byrne
et al., 2010; Weiner et al., 2014), and the provision of
unnecessary biopsies (Wiener et al., 2011), that warrant
consideration in the decision-making process and could
impact follow-up and program adherence if not properly
addressed prior to screening.

Study strengths and limitations
There are several limitations to this largely descriptive study
of early lung cancer screening adopters. First, the data are
from a period prior to release of the NLST findings and
changes in recommendations for lung cancer screening.
However, as described in the “Introduction” section, the
“choice setting” for this study more closely emulates the
current situation for most individuals making decisions
about lung cancer screening than more recently collected
data which use hypothetical survey responses or individuals
being screened in the context of a clinical trial. Second, we
report on a small sample size with no ability to comment on
survey non-respondents. However, these data may be helpful in designing subsequent research in this emerging area of
lung cancer prevention and control. Third, this study
describes individuals living in two relatively different communities who paid out-of-pocket for LDCT-based lung cancer screening prior to the updated USPSTF guideline.
Results cannot be reliably generalized to other populations
but may provide guidance for subsequent development of
interventions seeking to support informed and shared decision-making about lung cancer screening participation.
Finally, the data collected in this study were self-reported;
there may be potential for some degree of responder bias
and recall bias, given that some participants had participated
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in screening up to 12 months prior to participation. Despite
these limitations, data collected from lung cancer screening
early adopters who sought and received lung cancer screening offer a unique and valuable perspective on lung cancer
screening decision-making as implementation expands. To
our knowledge, no other studies have reported data from
similar populations undergoing lung cancer screening in a
community setting and outside of a clinical trial.

Conclusion
This study found that individuals who received LDCTbased lung cancer screening in a community setting generally viewed screening in a highly positive light. However,
on the whole, individuals being screened did not seek
detailed information about screening nor consulted trusted
health care clinicians about this decision. The paucity of
discussions between screeners and health care clinicians
runs counter to current lung cancer screening guidelines,
which strongly emphasize, and in some contexts mandate,
integration of patient counseling practices using shared
decision-making. These guidelines stress the importance of
informed patients making screening choices in collaboration with healthcare providers who communicate the balance of benefits, harms, and the uncertainties of screening
(Weiner and Slatore, 2013). To achieve the shared decisionmaking standards set forth by the Centers for Medicare &
Medicaid Services, efforts are needed to develop, rigorously evaluate, and promote the use of evidence-based lung
cancer screening decision tools. These tools need to provide patients with unbiased information about the potential
sequelae of screening, facilitate informed decision-making,
and encourage discussions with healthcare clinicians.
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